NYSX provides concentrated exposure to the 100 largest companies listed on the New York Stock Exchange by market cap, offering a middle ground between the S&P 500's breadth and single-stock concentration. This ETF targets investors who want blue-chip exposure without the Nasdaq's tech tilt or smaller companies that dilute large-cap returns.
How It Works
The fund tracks an index of the NYSE's 100 biggest companies ranked by float-adjusted market capitalization, rebalanced quarterly. Unlike the S&P 500's committee-based selection, this is purely rules-based sizing, which means no subjective quality screens. The NYSE-only restriction creates an inherent value tilt since many high-growth tech giants list on Nasdaq, resulting in heavier financials and industrials exposure than typical large-cap funds.
Key Features
- Zero expense ratio makes it cheaper than SPY (0.09%) for similar large-cap exposure
- NYSE-only listing requirement naturally underweights tech mega-caps versus market-cap weighted alternatives
- More concentrated than S&P 500 (100 vs 500 stocks) but broader than Dow Jones (30 stocks)
Risks
- Exchange concentration risk: missing Nasdaq-listed giants like Apple, Microsoft, and Google could lag in tech rallies by 10-20%
- New fund with no assets or trading history means wide bid-ask spreads and potential tracking errors of 50+ basis points
- Quarterly rebalancing in a concentrated portfolio could generate higher turnover and tax drag than annual rebalancers
Who Should Own This
Best suited for fee-conscious investors who specifically want to underweight big tech while maintaining large-cap exposure, or those building a barbell with separate Nasdaq allocation. The zero expense ratio makes it attractive for buy-and-hold investors comfortable with the NYSE bias. Not appropriate for those seeking broad market representation or expecting this to track the S&P 500.